RightFit
RecruitingNot applicable

Evaluation of a Decision-Support Tool for Blood Biomarker Testing for Alzheimer's Disease in Primary Care

Pilot Evaluation of a Tool to Support Communication About Blood Biomarker Testing for Cognitive Complaints in Primary Care

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
50 Years and older
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Questionnaires

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Simulation 1: The investigators will assess the usability and acceptability of the decision-support tool through direct observation and surveys of PCPs participating in high-fidelity simulations of clinical encounters (N=15)."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests a tool that helps primary care providers talk with patients about blood tests for signs of Alzheimer's disease. Researchers will check if the tool is easy to use and helps patients and providers make decisions together. The study is for primary care providers and adults age 50 or older who live independently in the community.

The goal of the current study is to evaluate a decision-support tool intended to help primary care providers (PCPs) communicate with patients about blood biomarker testing for Alzheimer's Disease, enhancing shared-decision making and information sharing in the clinical space. The main questions it aims to answer are: * Is the decision-support tool accepted and easy to use for PCPs? * Does using the tool improve shared decision-making during clinical encounters? Researchers will compare clinical encounters between PCPs who do not use the tool to discuss blood biomarker testing for Alzheimer's Disease, versus PCPs who have been trained to utilize the tool during clinical encounters to see whether the tool effectively facilitates shared-decision making.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • For practice sessions 1 and 2: Primary care providers with experience and interest in finding memory and thinking problems.
  • For practice session 2: Adults age 50 or older who live in the community.

Who can't join

  • No exclusion rules are listed for primary care providers.
  • Adults who are not fluent in English.
  • Adults younger than 50.
  • Adults already diagnosed with memory or thinking problems.
  • Adults who have someone currently authorized to make medical decisions for them.
  • Adults who do not live independently in the community.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Simulation 1 and Simulation 2: PCPs with experience and interest in cognitive diagnosis. * Simulation 2: community dwelling older adults age 50 or older are eligible. Exclusion Criteria (PCP): none Participant Exclusion Criteria: * Not fluent in English * age \<50 years * pre-existing diagnosis of cognitive impairment * having an activated medical decision-make r or not living independently in the community. There will be no exclusion based upon sex/gender, race, or ethnicity.

Study sites (1)

WI